Loss of SLC1A3 reduces tumor cell resistance to Gln starvation and inhibits tumor cell growth
The study will investigate whether an individuals genetic makeup influences the risk of developing acute pancreatitis while taking GLP-1 receptor agonists, a class of medicines used for Type 2 diabetes and weight loss
In rodent models of allergic asthma, GLP1 drugs have been shown to: Lower airway eosinophil counts Decrease inflammatory cytokines such as IL-5 and IL-13 Improve overall airway responsiveness These findings are promising and show how GLP1 medications might benefit the lungsnot just the pancreas or the brain
Some patients use 0.125 mg or even lower starting doses and make tiny incremental increases
Infants born of mothers who have received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M